1-20 of 21
Authors: Dan Atar
Save search
Sort by
Journal Article

Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy: A clinical consensus statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care (ACVC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy and the European Association for Haemophilia and Allied Disorders (EAHAD)

PDF
Dan Atar and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 275–289, https://doi.org/10.1093/ehjcvp/pvaf006
Published: 26 March 2025
Journal Article
EDITOR'S CHOICE

Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis

PDF
Bruna Gigante and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 7, November 2024, Pages 614–645, https://doi.org/10.1093/ehjcvp/pvae064
Published: 05 September 2024
Journal Article

The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics

PDF
Anna Meta Dyrvig Kristensen and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 3, April 2024, Pages 175–183, https://doi.org/10.1093/ehjcvp/pvad093
Published: 28 November 2023
Journal Article
EDITOR'S CHOICE

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease

PDF
Marco Valgimigli and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 462–496, https://doi.org/10.1093/ehjcvp/pvad032
Published: 29 April 2023
Journal Article
EDITOR'S CHOICE

Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)

PDF
Eliano Pio Navarese and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 3, April 2023, Pages 271–290, https://doi.org/10.1093/ehjcvp/pvad016
Published: 03 March 2023
Journal Article

Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial

PDF
Raffaele De Caterina and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 3, May 2022, Pages 227–235, https://doi.org/10.1093/ehjcvp/pvaa140
Published: 28 December 2020
Journal Article

The perils of data sharing, meta-analyses, and estimating cardiovascular risk

PDF
Thomas A Marciniak and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages e55–e57, https://doi.org/10.1093/ehjcvp/pvaa109
Published: 17 September 2020
Journal Article
EDITOR'S CHOICE

Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases

PDF
Gianluigi Savarese and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 2, March 2020, Pages 86–93, https://doi.org/10.1093/ehjcvp/pvz036
Published: 08 August 2019
Journal Article
EDITOR'S CHOICE

Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke

PDF
Patrick Sulzgruber and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 3, July 2019, Pages 171–180, https://doi.org/10.1093/ehjcvp/pvz016
Published: 23 May 2019
Journal Article

Ivabradine for heart failure: regulatory differences in Europe and United States

PDF
Thomas A Marciniak and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 2, April 2019, Pages 119–121, https://doi.org/10.1093/ehjcvp/pvz006
Published: 01 February 2019
Journal Article

Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy

PDF
Sverre E Kjeldsen and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 2, April 2019, Pages 122–123, https://doi.org/10.1093/ehjcvp/pvz005
Published: 30 January 2019
Journal Article

Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis

PDF
Magnus Dahl Aarvik and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 1, January 2019, Pages 12–20, https://doi.org/10.1093/ehjcvp/pvy034
Published: 06 September 2018
Journal Article

Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System

PDF
Victor L Serebruany and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 4, October 2019, Pages 210–215, https://doi.org/10.1093/ehjcvp/pvy035
Published: 06 September 2018
Journal Article

Peripheral arterial disease and limb salvage: a new arena for the cardiologist

PDF
Basil S Lewis and Dan Atar
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 3, July 2018, Pages 136–137, https://doi.org/10.1093/ehjcvp/pvy014
Published: 18 June 2018
Journal Article

How does the TRS 2°P score relate to real-world patients?

PDF
Marc P Bonaca and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 2, April 2018, Pages 72–74, https://doi.org/10.1093/ehjcvp/pvy004
Published: 05 March 2018
Journal Article

Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study

PDF
Hanna Fröhlich and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 2, April 2018, Pages 82–92, https://doi.org/10.1093/ehjcvp/pvx013
Published: 05 May 2017
Journal Article

Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry

PDF
Judit Papp and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 3, Issue 3, July 2017, Pages 147–150, https://doi.org/10.1093/ehjcvp/pvx003
Published: 17 March 2017
Journal Article

European Heart Journal-Cardiovascular Pharmacotherapy in 2016: entering a new level of international recognition

PDF
Dan Atar
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 3, Issue 1, January 2017, Pages 3–4, https://doi.org/10.1093/ehjcvp/pvw024
Published: 04 January 2017
Journal Article

Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial

PDF
Justin A. Ezekowitz and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 1, Issue 2, April 2015, Pages 86–94, https://doi.org/10.1093/ehjcvp/pvu024
Published: 17 March 2015
Journal Article

ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry

PDF
Jonathan De Blois and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 1, Issue 1, January 2015, Pages 31–36, https://doi.org/10.1093/ehjcvp/pvu010
Published: 02 January 2015